# Specification Quality Checklist: Prediction/Evidence Collection and Precomputed Adapter

**Purpose**: Validate specification completeness and quality before planning

**Created**: 2026-10-17

**Feature**: [Feature 002 specification](../spec.md)

## Content Quality

- [x] No implementation details (languages, frameworks, APIs)
- [x] Focused on user value and business needs
- [x] Written for non-technical stakeholders
- [x] All mandatory sections completed

## Requirement Completeness

- [x] No [NEEDS CLARIFICATION] markers remain
- [x] Requirements are testable and unambiguous
- [x] Success criteria are measurable
- [x] Success criteria are technology-agnostic (no implementation details)
- [x] All acceptance scenarios are defined
- [x] Edge cases are identified
- [x] Scope is clearly bounded
- [x] Dependencies and assumptions identified

## Feature Readiness

- [x] All functional requirements have clear acceptance criteria
- [x] User scenarios cover primary flows
- [x] Feature meets measurable outcomes defined in Success Criteria
- [x] No implementation details leak into specification

## Notes

- **Validation result: 16/16 passing.** This is a specification-quality review, not
  implementation verification. The five material clarification decisions are recorded
  in the specification and are ready for planning.
- User-required existing contract names and versioned JSON are compatibility constraints,
  not a selected implementation stack or new API design. Internal entity meanings do not
  invent external PD fields. Prioritized stories, edge cases and traceability are present.
- **Resolved clarifications:** C1 requires owner-supplied contributor mappings checked
  against exact registrations; C2 requires a trusted integration's source-specific checked
  output-to-contributor link before precomputed admission; C3 rejects probability-only
  outputs without a compliant registered class mapping. FR-011/019 retain valid primary
  predictions with explicit incomplete optional evidence. The owner or trusted integration
  may supply required opaque associations and evidence meanings separately, subject to
  source-contract checks. No safety readiness is inferred.
- **Model-agnostic scope review:** Requirements and SC-005 now apply to arbitrary eligible
  registered classifiers and components with different contributor counts, disease/label
  names and algorithms. US2.6/FR-014 explicitly cover different declared source contracts;
  US3.1 and traceability no longer depend on three contributors. Calibration/explanation
  spaces, target semantics, cohort-scope provenance and missing-evidence safeguards remain.
- **Integration example:** PD handoff retained in a non-normative reference section with
  an optional synthetic PD-like scenario. Its actual schema is unavailable; this limits
  direct PD compatibility claims only. Each source requires its own declared contract.
  No model artifact, patient record or clinical dataset was inspected.
- **Revalidation: 12/16 -> 16/16 passing.** Feature 001's mandatory class mapping,
  exact identity/compatibility, privacy and separation from safety assessment remain.
  These are documentation clarifications only; no plan, application code or tests were made.
